Letko, Brosseau & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96.6M | Buy |
|
|||||
|
2025
Q1 | $97.5M | Sell |
|
|||||
|
2024
Q4 | $103M | Buy |
|
|||||
|
2024
Q3 | $86.6M | Sell |
|
|||||
|
2024
Q2 | $90.7M | Buy |
|
|||||
|
2024
Q1 | $86.8M | Buy |
|
|||||
|
2023
Q4 | $87.8M | Buy |
|
|||||
|
2023
Q3 | $70M | Buy |
|
|||||
|
2023
Q2 | $76.1M | Buy |
|
|||||
|
2023
Q1 | $67.6M | Buy |
|
|||||
|
2022
Q4 | $84.2M | Sell |
|
|||||
|
2022
Q3 | $73.1M | Sell |
|
|||||
|
2022
Q2 | $93.1M | Sell |
|
|||||
|
2022
Q1 | $100M | Sell |
|
|||||
|
2021
Q4 | $120M | Sell |
|
|||||
|
2021
Q3 | $90.7M | Sell |
|
|||||
|
2021
Q2 | $88.5M | Buy |
|
|||||
|
2021
Q1 | $53.1M | Sell |
|
|||||
|
2020
Q4 | $55.4M | Sell |
|
|||||
|
2020
Q3 | $60.9M | Sell |
|
|||||
|
2020
Q2 | $59.9M | Sell |
|
|||||
|
2020
Q1 | $63.1M | Buy |
|
|||||
|
2019
Q4 | $75.6M | Sell |
|
|||||
|
2019
Q3 | $71.9M | Sell |
|
|||||
|
2019
Q2 | $89.6M | Sell |
|
|||||
|
2019
Q1 | $93.7M | Sell |
|
|||||
|
2018
Q4 | $102M | Sell |
|
|||||
|
2018
Q3 | $127M | Sell |
|
|||||
|
2018
Q2 | $132M | Sell |
|
|||||
|
2018
Q1 | $132M | Sell |
|
|||||
|
2017
Q4 | $141M | Sell |
|
|||||
|
2017
Q3 | $145M | Sell |
|
|||||
|
2017
Q2 | $138M | Sell |
|
|||||
|
2017
Q1 | $144M | Sell |
|
|||||
|
2016
Q4 | $140M | Sell |
|
|||||
|
2016
Q3 | $153M | Sell |
|
|||||
|
2016
Q2 | $166M | Sell |
|
|||||
|
2016
Q1 | $142M | Sell |
|
|||||
|
2015
Q4 | $179M | Sell |
|
|||||
|
2015
Q3 | $182M | Sell |
|
|||||
|
2015
Q2 | $215M | Sell |
|
|||||
|
2015
Q1 | $226M | Sell |
|
|||||
|
2014
Q4 | $208M | Sell |
|
|||||
|
2014
Q3 | $200M | Sell |
|
|||||
|
2014
Q2 | $203M | Buy |
|
|||||
|
2014
Q1 | $219M | Sell |
|
|||||
|
2013
Q4 | $214M | Sell |
|
|||||
|
2013
Q3 | $221M | Sell |
|
|||||
|
2013
Q2 | $224M | Buy |
|